logo
REJECTION OF SPONTANEOUSLY ACCEPTED RAT LIVER ALLOGRAFTS WITH RECIPIENT INTERLEUKIN-2 TREATMENT OR DONOR IRRADIATION1,2
ANTI-GAL IgG ANTIBODIES IN SERA OF NEWBORN HUMANS AND BABOONS AND ITS SIGNIFICANCE IN PIG XENOTRANSPLANTATION1
THE EFFECT OF SMALL BOWEL TRANSPLANTATION ON THE MORPHOLOGY AND PHYSIOLOGY OF INTESTINAL MUSCLE
RENOPROTECTIVE EFFECTS OF THE 21-AMINOSTEROID U74389G IN ISCHEMIA-REPERFUSION INJURY AND COLD STORAGE PRESERVATION1,2
COMPARISON OF VARIOUS LAZAROID COMPOUNDS FOR PROTECTION AGAINST ISCHEMIC LIVER INJURY1,2
RIGHT VENTRICULAR FAILURE-INSIGHTS PROVIDED BY A NEW MODEL OF CHRONIC PULMONARY HYPERTENSION1
ATTENUATION OF ISCHEMIC LIVER INJURY BY AUGMENTATION OF ENDOGENOUS ADENOSINE1,2
TACROLIMUS RESCUE THERAPY FOR RENAL ALLOGRAFT REJECTION-FIVE-YEAR EXPERIENCE1
LAPAROSCOPIC ASSISTED LIVE DONOR NEPHRECTOMY - A COMPARISON WITH THE OPEN APPROACH1
IMMUNOLOGIC AND PATIENT SELECTION STRATEGIES FOR SUCCESSFUL UTILIZATION OF LESS THAN 15 KG PEDIATRIC DONOR KIDNEYS-LONG TERM EXPERIENCES WITH 40 TRANSPLANTS1
SIMULTANEOUS PANCREAS/KIDNEY TRANSPLANTATION-A COMPARISON OF ENTERIC AND BLADDER DRAINAGE OF EXOCRINE PANCREATIC SECRETIONS1
WEANING OF IMMUNOSUPPRESSION IN LIVER TRANSPLANT RECIPIENTS1 2
HEPATIC ARTERY STENOSIS AFTER LIVER TRANSPLANTATION-INCIDENCE, PRESENTATION, TREATMENT, AND LONG TERM OUTCOME1
A STATEWIDE, POPULATION-BASED, TIME SERIES ANALYSIS OF ACCESS TO LIVER TRANSPLANTATION1
ORGAN PRESERVATION SOLUTIONS IN HEART TRANSPLANTATION-PATTERNS OF USAGE AND RELATED SURVIVAL1
PEDIATRIC LUNG TRANSPLANTATION-ARE THERE SURGICAL CONTRAINDICATIONS?1
THE ROLE OF PCR IN THE DIAGNOSIS AND MANAGEMENT OF CMV IN SOLID ORGAN RECIPIENTS
DEPENDENCE OF ACQUIRED SYSTEMIC TOLERANCE TO RAT ISLET ALLOGRAFTS INDUCED BY INTRATHYMIC SOLUBLE ALLOANTIGENS ON HOST RESPONSIVENESS, MHC DIFFERENCES, AND TRANSIENT IMMUNOSUPPRESSION IN THE HIGH RESPONDER RECEPIENT1,2
INDUCTION OF DONOR SPECIFIC TRANSPLANTATION TOLERANCE TO CARDIAC ALLOGRAFTS FOLLOWING TREATMENT WITH NONDEPLETING (RIB 5/2) OR DEPLETING (OX-38) ANTI-CD4 mAb PLUS INTRATHYMIC OR INTRAVENOUS DONOR ALLOANTIGEN1,2
ASIALOGLYCOPROTEIN/ASIALOGLYCOPROTEIN RECEPTOR (AGP-AGPr) INTERACTION IS AN IMPORTANT MECHANISM FOR THE UPTAKE OF FK506 BY HEPATOCYTES1,2
PREVENTION OF AUTOIMMUNE ISLET ALLOGRAFT DESTRUCTION BY ENGRAFTMENT OF DONOR T CELLS1
MORPHOLOGY OF hDAF (CD55) TRANSGENIC PIG KIDNEYS FOLLOWING EX-VIVO HEMOPERFUSION WITH HUMAN BLOOD1,2
ANALYSIS OF FUNCTIONAL RENAL ALLOGRAFT TOLERANCE WITH SINGLE-DOSE RAPAMYCIN BASED INDUCTION IMMUNOSUPPRESSION1
IMMUNOLOGIC BARRIERS TO HEPATIC ADENOVIRAL GENE THERAPY FOR TRANSPLANTATION
APOPTOSIS IN MURINE CARDIAC GRAFTS1,2,3
THE USE OF HIBERNATION INDUCTION TRIGGERS FOR CARDIAC TRANSPLANT PRESERVATION1,2